This was further supported by another model which provided genetic and pharmacologic proof that activation of EGFR in the proximal tubular cells is crucial in the recovery from AKI, by generating mice with EGFR mutation in RPTCs (Chen et al., 2012). The gene discussed is EGFR; the disease is acute kidney injury.